# LEUKERAN
> **NDA010669** · New Drug Application · Sponsor: WAYLIS THERAP · Approved 1957-03-18
## Drug
- **FDA Application Number:** NDA010669
- **Application type:** New Drug Application
- **Brand name:** LEUKERAN
- **Generic name:** CHLORAMBUCIL
- **Active ingredients:** CHLORAMBUCIL
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** WAYLIS THERAP
- **Manufacturer:** Waylis Therapeutics LLC
- **First approval:** 1957-03-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010669)
---
*AI Analytics · CC0 1.0*